You are here

  • Home
  • Archive
  • Volume 9, Issue 2
  • Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplanta…

Article metrics

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
Post-transplantation cyclophosphamide reduces the incidence of acute graft-versus-host disease in patients with acute myeloid leukemia/myelodysplastic syndromes who receive immune checkpoint inhibitors after allogeneic hematopoietic stem cell transplantation

 

Online download statistics by month:

Online download statistics by month: February 2021 to March 2024

AbstractFullPdf
Feb 2021868635
Mar 2021379378130
Apr 202114714755
May 202110510535
Jun 202110210231
Jul 2021939320
Aug 2021999935
Sep 2021595923
Oct 2021727233
Nov 2021656337
Dec 2021616117
Jan 2022525322
Feb 2022404023
Mar 2022505018
Apr 2022838523
May 2022686923
Jun 2022676921
Jul 2022505415
Aug 2022707016
Sep 2022525219
Oct 2022464628
Nov 2022262612
Dec 2022474710
Jan 2023404221
Feb 2023596015
Mar 2023565823
Apr 2023444415
May 2023272713
Jun 2023373710
Jul 2023696914
Aug 202370709
Sep 2023676814
Oct 2023484815
Nov 2023666614
Dec 2023949417
Jan 2024333522
Feb 2024282818
Mar 2024303119
Total26872703920